Arca
Skip to content
Tools
Tools

Sarcoidosis

Drug research and approvals for sarcoidosis: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 49 studies of sarcoidosis are recruiting on ClinicalTrials.gov, Health Canada has authorized 5 drug trials for it since 2013, and FDA has 0 approved and 14 open orphan designations naming it.

  • Recruiting worldwide: 49
  • Trials authorized in Canada: 5
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting now

Newest posted first, of 49 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Approved 3

Phase 3 2

Phase 2 12 of 20

Phase 1 or earlier 3

How its trials ended

279 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 59 whose ending is known, 36% met their primary endpoint, 10% missed it and 54% stopped early.

  • Completed, result not reported11140%
  • Ongoing7025%
  • Status unknown3914%
  • Met its primary endpoint218%
  • Stopped: other or unclear207%
  • Missed its primary endpoint62%
  • Stopped: enrollment or feasibility62%
  • Stopped: funding31%
  • Stopped: sponsor or business decision21%
  • Stopped: lack of efficacy1<1%

Trials authorized in Canada

Newest first; search them all in Canada trials
Sep 15, 2026A phase 2 randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of tulisokibart in participants with active…Tulisokibart (MK-7240) / PrednisoneMerck & Co. (MSD)Pending
Jul 7, 2026A phase 2/3 randomized, double-blind, placebo-controlled, dose-ranging study to investigate the safety and efficacy of oral brepocitinib in adults with…Brepocitinib (PVT-2201)Priovant TherapeuticsPending
Oct 27, 202018f-fluorodeoxyglucose in positron emission tomographyFluorodeoxyglucose (2-[18F]FLUORO-2-DEOXY-D-glucose)Eastern Health Regional Health AuthorityOngoing
Jul 2, 2019A multicenter, randomized, double-blind, placebo-controlled study in participants with sarcoidosis-associated pulmonary hypertension (SAPH) to assess the…SelexipagJohnson & JohnsonClosed
Aug 29, 2018Cardiac sarcoidosis multi-center randomized controlled trial (chasm cs- rct)Prednisone/ MethotrexateOttawa Heart Institute Research CorporationOngoing

FDA orphan designations

Approved first, then open designations, newest first
Apr 26, 2022Umbilical cord mesenchymal stem cell secretomeTreatment of sarcoidosisNRG Sciences LLCDesignated
Jan 5, 2022Human IgG1Fc- iMod domain (amino acids 2-60) of human HARS…Treatment of sarcoidosisaTyr PharmaDesignated
Jul 27, 2021SirolimusTreatment of SarcoidosisAI TherapeuticsDesignated
Nov 24, 2020Humanized Recombinant Anti-Tumor Necrosis Factor ?…Treatment of sarcoidosisXentria, Inc.Designated
Jul 23, 2020AviptadilTreatment of sarcoidosisRelief Therapeutics International SADesignated
Jul 21, 2020Alidornase alfaTreatment of sarcoidosisSarcoMed USA, Inc.Designated
Jan 14, 20205-(4-((2S,5S)-5-(4-chlorobenzyl)-2-methylmorpholino)piperidi…Treatment of sarcoidosisMolecure S.A. (previously OncoArendi S.A.)Designated
Jun 4, 2019Dornase alfaTreatment of sarcoidosisSarcoMed USA, LLCDesignated
Jun 13, 2016L-pyr-L-glu-L-gln-L-leu-L-glu-L-arg-L-ala-L-leu-L-asn-L-ser-…Treatment of sarcoidosis.Araim Pharmaceuticals, Inc.Designated
Sep 13, 2011L-pyr-L-glu-L-gln-L-leu-L-glu-L-arg-L-ala-L-leu-L-asn-L-ser-…Treatment of neuropathic pain in patients with sarcoidosis.Araim Pharmaceuticals, Inc.Designated
Feb 4, 2011ThymopentinTreatment of sarcoidosis.Mondobiotech Laboratories AGDesignated
Aug 9, 2006Clindamycin hydrochlorideTreatment of sarcoidosisAutoimmunity Research FoundationDesignated
Mar 28, 2006Minocycline hydrochlorideTreatment of sarcoidosisAutoimmunity Research FoundationDesignated
Feb 16, 2005Nitric oxideDiagnosis of sarcoidosisSensorMedics CorporationDesignated

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.